MedPath

Comparing two devices which help the patient breathe under general anaesthesia - the endotracheal tube and the supreme laryngeal mask airway, for patients undergoing gall bladder removal surgery laparoscopically.

Completed
Conditions
Patients with gall stones, for removal of the gall bladder, by laparoscopic surgery.
Registration Number
CTRI/2017/11/010452
Lead Sponsor
PD Hinduja National Hospital and Medical Research Centre
Brief Summary

**Hypothesis**- Theventilation of patients is adequate with both Supreme Laryngeal Mask Airway (LMAS) and Endotracheal Tube (ETT) undergoinglaparoscopic cholecystectomy under general anesthesia. My question is whetherLMAS is better than or similar to ETT in the ventilation of the patient.

**Rationale-** Laparoscopic cholecystectomy is done under general anesthesia.Under general anesthesia the patient cannot breathe on his own, so we need toput in an airway device to mechanically ventilate his lungs.

Till date, the cuffed endotracheal tube was considered as the goldstandard for providing a safe seal in the larynx, especially for laparoscopicprocedures under general anesthesia. The disadvantages of tracheal intubation,which involves rigid laryngoscopy, are in terms of concomitant haemodynamicresponses and damage to the oropharyngeal structures at insertion.Postoperative sore throat is also a serious concern. This precludes the globalutility of the tracheal tube and requires a better alternative. Over a periodof time, new airway devices have been added to the anaesthesiologist’sarmamentarium.

Supreme laryngeal mask airway (LMAS) is a supraglottic device whichhas an advanced cuff to provide a better seal around the laryngeal opening and permits peak airway pressure more than 30 cm waterwithout leak. It has a drain tube parallel to theventilation tube which permits drainage of passively regurgitated gastric fluidaway from the airway and serves as a passage for gastric tube. The LMAS is single use, latex freeand is made of medical grade PVC. The firm, elliptical andanatomically shaped airway tube facilitates easy insertion, without placingfingers in the patient’s mouth or placing an introducer tool for insertion.

This study is therefore undertaken to see if LMAS provides betteror similar ventilation than ETT in healthy adult patients undergoinglaparoscopic cholecystectomy under general anesthesia.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
132
Inclusion Criteria

Consecutive 132 American Society of Anesthesiologists (ASA) status I and II adults of either sex, aged 20-65 years and body weight 40-80 kg, scheduled for elective laparoscopic cholecystectomy, under general anaesthesia, who had given consent to participate was recruited.

Exclusion Criteria

Patients with anticipated difficult airway, Obesity (body mass index >30 kg/m2), Oropharyngeal pathology, Cardiopulmonary disease, Cervical spine fracture or instability, Increased risk of aspiration.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Adequacy of ventilationFrom insertion of airway device to end of anaesthesia.
i) Quality of glottic airway seal – Difference between Inspired tidal volume andFrom insertion of airway device to end of anaesthesia.
Expired tidal volumeFrom insertion of airway device to end of anaesthesia.
ii) Oxygen saturationFrom insertion of airway device to end of anaesthesia.
iii) EtCO2From insertion of airway device to end of anaesthesia.
iv) Peak airway pressuresFrom insertion of airway device to end of anaesthesia.
Secondary Outcome Measures
NameTimeMethod
2. Ease of InsertionTime required for achieving effective airway and the number of attempts for securing

Trial Locations

Locations (1)

P.D. Hinduja National Hospital and Medical Research Centre

🇮🇳

Mumbai, MAHARASHTRA, India

P.D. Hinduja National Hospital and Medical Research Centre
🇮🇳Mumbai, MAHARASHTRA, India
Deepak Bhushan
Principal investigator
9821859729
lion.deepak@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.